FMP
Propanc Biopharma, Inc.
PPCB
PNK
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
0.0012 USD
0.0001 (8.33%)
About
ceo
Mr. James Nathanielsz
sector
Healthcare
industry
Biotechnology
website
https://www.propanc.com
exchange
PNK
Description
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
CIK
0001517681
ISIN
US74346N4043
CUSIP
74346N404
Address
302, 6 Butler Street
Phone
61 3 9882 0780
Country
AU
Employee
1
IPO Date
Nov 12, 2012
Summary
CIK
0001517681
Exchange
PNK
Industry
Biotechnology
Sector
Healthcare
CUSIP
74346N404
ISIN
US74346N4043
Country
AU
Price
0
Beta
1.17
Volume Avg.
4.12M
Market Cap
3.95B
Shares
-
52-Week
1.0E-4-0.2625
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.12
P/B
-
Website
https://www.propanc.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PPCB News
It looks like there's no news available.
